德國建議 AstraZeneca疫苗僅供65歲以下民眾接種 | 國際 cna.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cna.com.tw Daily Mail and Mail on Sunday newspapers.
| UPDATED: 17:19, Tue, Jan 26, 2021
Link copied Sign up for FREE now and never miss the top politics stories again
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters.
Sometimes they ll include recommendations for other related newsletters or services we offer.
Our Privacy Notice explains more about how we use your data, and your rights.
You can unsubscribe at any time.
The health ministry insisted the claims made in German media last night were based on confused analysis of a study into the effectiveness of the AstraZeneca jab. It was reported that doses of the jab given to adults over-65s had been just eight percent effective. German health ministry officials explained that the eight percent actually referred to the number of people in the study between 56 and 69 years old.
The British-Swedish pharmaceutical giant said German media reports claiming that the vaccine had an 8% efficacy rate in people above 65 were "completely incorrect."
Coronavirus | AstraZeneca rejects reports on vaccine efficacy in elderly
Updated:
Updated:
Share Article
AAA
Germany’s Health Ministry on Tuesday joined AstraZeneca in rubbishing reports quoting unnamed government sources that claimed the British-Swedish company’s Covid-19 vaccine showed little efficacy for people above 65.
Handelsblatt daily had reported on Monday that Berlin had estimated that the efficacy of the jab in people above 65 was just 8%, citing unnamed sources. Separately,
Bild daily, quoting anonymous sources, put the efficacy rate at “less than 10%”.
But Germany’s Health Ministry said it appears that there have been some mix up in the reports.
“Around 8% of the volunteers in AstraZeneca’s efficacy studies were around 56 and 69 years old and three to 4% are above 70 years old,” said the Ministry.